Medibank Private Ltd Stock Price Today (NSE: MPL)
Fundamental Score
Medibank Private Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Medibank Private Ltd share price today is ₹5.47, down 3.08% on NSE/BSE as of 30 March 2026. Medibank Private Ltd (MPL) is a Small-cap company in the Packaging sector with a market capitalisation of ₹11.29 (Cr). The 52-week high for MPL share price is ₹11.90 and the 52-week low is ₹5.92.
Medibank Private Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Medibank Private Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Medibank Private Share Price: A Financial Stability Analysis
The packaging industry, often unseen by consumers, is currently undergoing a period of innovation driven by sustainability concerns and increasing e-commerce demands. This analysis examines the financial stability of Medibank Private Ltd, focusing specifically on the Medibank Private share price, which currently stands at ₹7.650000095367432. This assessment is part of an 80-parameter fundamental audit, verified by Sweta Mishra, designed to evaluate the company's overall financial health.
One crucial indicator of financial health is the Price-to-Earnings (PE) ratio. Currently, no PE ratio is available for Medibank Private Ltd. The absence of a PE ratio can make valuation comparisons challenging, requiring deeper investigation into earnings and potential future profitability. Meanwhile, Sector Peers like
Vinayak Polycon International Ltd can be contrasted, including assessments of the quality of management. Comparing the management's strategic direction and execution capabilities across these companies provides valuable insights into potential performance discrepancies.A significant cause for concern is the exceptionally low Return on Capital Employed (ROCE) of -4800.0%. ROCE is a key metric that measures a company's profitability relative to the total capital employed. A negative ROCE of this magnitude suggests significant inefficiencies in capital allocation and potentially indicates that the company is struggling to generate profits from its investments.
This dramatically negative ROCE directly impacts the company's "moat," or its competitive advantage. A robust ROCE typically indicates a strong and sustainable moat. However, the current figure implies that Medibank Private Ltd may be vulnerable to competitive pressures, as its capital is not being deployed effectively to generate returns. This necessitates a comprehensive review of the company's operational efficiency, cost structure, and strategic positioning within the competitive landscape. Further investigation into the reasons behind this low ROCE is crucial to understanding the long-term sustainability of Medibank Private Ltd. This analysis is observational and intended for informational purposes only.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Medibank Private Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of MPL across key market metrics for learning purposes.
Positive Indicators
2 factors identified
Strong Cash Generation (₹178.65 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
4 factors identified
Suboptimal ROCE (-4800.00%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Low Promoter Commitment (24.00%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
Limited Institutional Interest (FII+DII: 0.01%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Medibank Private Ltd Financial Statements
Comprehensive financial data for Medibank Private Ltd including income statement, balance sheet and cash flow
About MPL (Medibank Private Ltd)
Medibank Private Ltd is a leading Australian private health insurer, providing a range of health insurance products and services to over 3.8 million members. With a history spannin...g over four decades, Medibank has established itself as a trusted and recognizable brand in the Australian healthcare landscape. Their core business revolves around offering comprehensive health cover options, catering to individuals, families, and corporate clients. Medibank aims to support its members' health and wellbeing through preventative care programs, health management resources, and access to a broad network of healthcare providers. They focus on simplifying the health insurance experience, providing digital tools and resources for members to manage their policies, and engaging with them to achieve their health goals. Medibank differentiates itself by actively engaging with the healthcare ecosystem to improve outcomes for its members. They invest in innovative healthcare initiatives, such as telehealth services, mental health programs, and partnerships with healthcare providers. Medibank also prioritizes member experience, striving to deliver seamless customer service and accessible support channels. They continually adapt their product offerings to meet the evolving needs of their members and address emerging health trends. Through these initiatives, Medibank aims to foster a more proactive and personalized approach to healthcare, empowering individuals to take control of their health and well-being journey. Medibank's commitment extends beyond health insurance, encompassing a broader purpose of contributing to a healthier Australia. They actively support community health initiatives, research programs, and advocacy efforts that promote health and wellbeing across the nation. Medibank also engages in public health campaigns to raise awareness about important health issues, such as preventative screening and mental health support. With a strong focus on innovation, customer-centricity, and social responsibility, Medibank continues to play a pivotal role in shaping the future of Australian healthcare.
Company Details
Key Leadership
Corporate Events
Latest News
MPL Share Price: Frequently Asked Questions
What is the current share price of Medibank Private Ltd (MPL)?
As of 30 Mar 2026, 12:02 pm IST, Medibank Private Ltd share price is ₹5.47. The MPL stock has a market capitalisation of ₹11.29 (Cr) on NSE/BSE.
Is MPL share price Overvalued or Undervalued?
MPL share price is currently trading at a P/E ratio of 0.00x, compared to the industry average of 21.55x. Based on this relative valuation, the Medibank Private Ltd stock appears to be Fairly Valued against its sector peers.
What is the 52-week high and low of MPL share price?
The 52-week high of MPL share price is ₹11.90 and the 52-week low is ₹5.92. These values are updated daily from NSE/BSE price data.
What factors affect the Medibank Private Ltd share price?
Key factors influencing MPL share price include quarterly earnings growth (Sales Growth: N/A%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Medibank Private Ltd a good stock for long-term investment?
Medibank Private Ltd shows a 5-year Profit Growth of 12.32% and an ROE of N/A%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of N/A before investing in MPL shares.
How does Medibank Private Ltd compare with its industry peers?
Medibank Private Ltd competes with major peers in the Packaging. Investors should compare MPL share price P/E of 0.00x and ROE of N/A% against the industry averages to determine competitive standing.
What is the P/E ratio of MPL and what does it mean?
MPL share price has a P/E ratio of N/Ax compared to the industry average of 21.55x. Investors pay ₹N/A for every ₹1 of annual earnings.
How is MPL performing according to Bull Run's analysis?
MPL has a Bull Run fundamental score of 10.4/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does MPL belong to?
MPL operates in the Packaging industry. This classification helps understand the competitive landscape and sector-specific trends affecting Medibank Private Ltd share price.
What is Return on Equity (ROE) and why is it important for MPL?
MPL has an ROE of N/A%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Medibank Private Ltd generates profits from shareholders capital.
How is MPL debt-to-equity ratio and what does it indicate?
MPL has a debt-to-equity ratio of N/A, which indicates conservative financing with low financial risk.
What is MPL dividend yield and is it a good dividend stock?
MPL offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Medibank Private Ltd shares.
How has MPL share price grown over the past 5 years?
MPL has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth 12.32%, and EPS Growth 12.32%.
What is the promoter holding in MPL and why does it matter?
Promoters hold 24.00% of MPL shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Medibank Private Ltd.
What is MPL market capitalisation category?
MPL has a market capitalisation of ₹11 crores, placing it in the Small-cap category.
How volatile is MPL stock?
MPL has a beta of N/A. A beta > 1 suggests the Medibank Private Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is MPL operating profit margin trend?
MPL has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.
How is MPL quarterly performance?
Recent quarterly performance shows Medibank Private Ltd YoY Sales Growth of N/A% and YoY Profit Growth of -9.09%.
What is the institutional holding pattern in MPL?
MPL has FII holding of 0.00% and DII holding of 0.01%. Significant institutional holding often suggests professional confidence in the Medibank Private Ltd stock.